View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
pharma services oehler|3 September 2019


The safety requirements for medicinal products are high and Swiss laws and regulations are constantly being adapted.

The safety requirements for medicinal products are high. Swiss laws and regulations are constantly being adapted. Patients, specialists and authorities demand more and more information. Adverse effects must be reported to Swissmedic. We would be happy to advise you.

Strategic consultation

Use our experience and know-how on a strategic level:

• Evaluation and optimisation of existing pharmacovigilance systems for Swiss pharmaceutical companies • Development of new pharmacovigilance systems including contracts and documentation • Providing the function of Responsible Person PV in Switzerland

Operational support

We would be delighted to support you with your daily business:

• Receiving and processing ADR notifications from Switzerland • Carrying out regular literature searches for Switzerland • Review and submission of PSURs/PBRERs and RMPs

This white paper highlights what it takes to bring a drug to the Swiss market, including the marketing authorisation application MAA), preapproval and launch preparation...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology